On Wednesday, BeiGene announced it closed on the purchase of a 42-acre site in Hopewell, where it will create a manufacturing campus and clinical research and development center.
The property at the 1.2 million-square-foot Princeton West Innovation Campus was sold by Lincoln Equities Group.
“Post pandemic, life sciences companies are increasingly seeking locations near their customer base in the U.S., and we are thrilled that BeiGene has chosen our Princeton West Innovation Campus for its important work,” said Lance Bergstein, managing director at Lincoln Equities. “We’re proud to help attract global companies to New Jersey, especially when it results in new jobs and investment in the region.”
Lincoln Equities Group and H.I.G. Realty Partners purchased the site, formerly owned by Bristol-Myers Squibb, in 2020. It features nine principal buildings with clinical manufacturing, plug-and-play biological laboratories and office space, along with freestanding R&D support space, storage facilities and a global data and command center, LEG said.
The Princeton West Innovation Campus is supported by a central utility complex that provides wastewater management, generator-backed electricity, chilled water and steam. Amenities at the sprawling campus include a full-service cafeteria, a fitness center, a freestanding child development center and multiple conference areas.
Lincoln Equities Group was represented by JLL’s Daniel Loughlin and Robert Klausner of Fox Rothschild LLP; financial terms of the deal were not disclosed.i